Google+ Facebook Twitter Twitter

Early results for gene editing study

Early, partial results from a historic gene editing study indicate that the treatment may be safe and having at least some of its hoped-for effect.

However, it is too soon to know whether it will ultimately succeed.

The results, announced in September, are from the first human test of gene editing in the body – an attempt to permanently change someone’s DNA to cure a disease.

In this case, they are tackling a genetic disorder called Hunter syndrome that often kills people in their teens. In two patients who got a medium dose of the treatment, urine levels of large sugar compounds that are hallmarks of Hunter syndrome had fallen by half, on average, four months later – a possible sign the treatment is working.

Two others who got a low dose have seen little change in these sugars so far.

However, there’s no way to know yet whether the change are due to the gene editing.

Related Articles

Breath testing for gut disorders

Small children may one day avoid invasive oesophageal tube-testing for gut damage and coeliac disease thanks to a new method. It involves blowing into a glass tube to provide effective diagnoses.


How to… embrace leadership

Clinical Scientist and Molecular Pathology Lead Siobhan Taylor discusses applying for a leadership programme and the benefits it has brought.


Approaches to lipid therapy

Consultant Chemical Pathologist Professor Tim Reynolds outlines drug developments over recent decades in lipid therapy.


molecular scissors

Jennifer Doudna is behind a pioneering gene editing technique, potential applications of which range from curing genetic diseases, to improving crops. She discusses the practical and ethical issues.